Wellbutrin SR and Wellbutrin XL contain the same active ingredient, bupropion, but they release it into your body at different speeds. That single difference changes how often you take the medication, what tablet strengths are available, and which conditions each version is approved to treat. Both are effective antidepressants with similar side effect profiles.
How the Two Formulations Release Medication
The “SR” stands for sustained release, and the “XL” stands for extended release. Both are designed to deliver bupropion more slowly than the original immediate-release tablet, but XL stretches the process out longer. SR reaches its peak blood concentration in about 3 hours, while XL takes roughly 5 hours. That slower absorption is why XL can be taken once a day instead of twice.
The immediate-release version of bupropion (plain Wellbutrin) peaks even faster, around 1.5 hours, and requires three doses per day. SR was developed to cut that down to two, and XL reduced it further to one. For most people, fewer daily doses means easier adherence and a more consistent level of medication throughout the day.
Dosing Schedule and Available Strengths
Wellbutrin SR is typically taken twice daily, starting at 150 mg in the morning with a second dose later in the day. Wellbutrin XL is taken once daily in the morning, also starting at 150 mg. After a few days, both can be increased to a total of 300 mg per day. The maximum recommended daily dose for either formulation is 450 mg, though seizure risk rises at higher doses (from roughly 0.1% below 300 mg/day to about 0.4% at 450 mg/day).
Wellbutrin SR comes in 100 mg, 150 mg, and 200 mg tablets. Wellbutrin XL comes in 150 mg and 300 mg tablets. The XL 300 mg tablet is particularly convenient because it delivers the full target dose in a single pill, while SR requires two separate tablets spaced apart during the day.
FDA-Approved Uses
This is one of the more meaningful differences between the two. Wellbutrin XL is FDA-approved for both major depressive disorder and the prevention of seasonal affective disorder (SAD). Wellbutrin SR is approved for major depressive disorder but does not carry the SAD indication. If your provider is prescribing bupropion specifically for seasonal depression, XL is the version with clinical trial data and formal approval backing that use.
Both formulations have also been widely used off-label. Bupropion SR, sold under the brand name Zyban, is separately approved as a smoking cessation aid. The underlying medication is identical.
Side Effects Are Essentially the Same
Because SR and XL deliver the same drug at the same total daily dose, their side effect profiles are very similar. A study comparing the two formulations in patients using bupropion for smoking cessation found no statistically significant differences in the frequency of any specific side effect. The most common issues across both versions were insomnia (about 6% of users), nausea (3.4%), anxiety (2.5%), and headache (2.5%).
Some people report that the twice-daily SR schedule causes a noticeable “peak and valley” pattern, with more activation or jitteriness after each dose. XL’s slower release can smooth that out. On the other hand, if insomnia is a problem, SR gives you the option of timing your second dose earlier in the afternoon so less medication is active at bedtime. XL delivers its full payload from a single morning dose, which you can’t split up.
Switching Between SR and XL
If you’re moving from one formulation to the other, the FDA labeling recommends keeping the same total daily dose. Someone taking 150 mg of SR twice daily (300 mg total) would switch to a single 300 mg XL tablet. No taper or washout period is needed because the active drug is identical. The transition is usually straightforward, though some people notice subtle differences in how they feel during the first few days as their body adjusts to the new release pattern.
Generic Versions and Bioequivalence
Both SR and XL are available as generics, which can significantly reduce cost. The generic history of bupropion XL 300 mg is worth knowing, though. The first generic XL 300 mg product (Budeprion XL) was approved through an unusual waiver process without direct bioequivalence testing at the 300 mg dose. When that testing was eventually performed, the product failed and was pulled from the market. A second generic from Watson was also later found non-equivalent and withdrawn.
That rocky start fueled real skepticism about generic bupropion XL, and you may still see warnings about it online. The situation has since been resolved. A rigorous clinical trial tested three remaining generic bupropion XL 300 mg products (from Par, Mylan, and Watson Labs) against the brand-name version in patients with major depression. All three generics were bioequivalent, with blood levels well within the standard 80 to 125% range, and showed essentially identical rates of symptom control. The generics currently on the market are considered reliable substitutes.
Which One Is Better for You
For most people, the choice comes down to convenience and individual response. XL’s once-daily dosing is simpler, and the 300 mg single tablet eliminates the need to remember a second dose. If you’re being treated for seasonal affective disorder, XL is the only version with that specific FDA approval.
SR can be a better fit if you prefer more control over timing, particularly if you’re sensitive to insomnia or if your insurance or pharmacy makes SR generics significantly cheaper. Some people also find that splitting the dose into two smaller peaks throughout the day feels smoother than one larger sustained release. Neither version is inherently more effective than the other at the same total daily dose.